Press "Enter" to skip to content

New patent expiration for Baxter Hlthcare drug BREVIBLOC

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Baxter Hlthcare drug BREVIBLOC

Annual Drug Patent Expirations for BREVIBLOC
Annual Drug Patent Expirations for BREVIBLOC

Brevibloc is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for BREVIBLOC.

The generic ingredient in BREVIBLOC is esmolol hydrochloride. Three suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Baxter Hlthcare drug BREVIBLOC
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions